Barriers to care for people with unclear visual loss—Data from a tertiary-level-of-care neuroinflammation center
The pre-referral use of specific neurovisual tests in people with multiple sclerosis with visual symptoms was low relative to non-specific procedures. This suggests heterogeneous integration of neurovisual testing across care levels. In light of the revised McDonald Criteria 2024, prospective multicenter studies should examine implementation and clinical impact.
Authors
- Eva-Maria Dorsch (ORCID: https://orcid.org/0009-0002-5872-1268)
- Charlotte Bereuter (ORCID: https://orcid.org/0009-0004-7172-8864)
- Ewelina Nowak
- Judith Bellmann–Strobl (ORCID: https://orcid.org/0000-0003-2615-1643)
- Jan Schroeter (ORCID: https://orcid.org/0000-0002-9592-9044)
- Janina Behrens (ORCID: https://orcid.org/0000-0002-9723-8087)
- Joseph Kuchling (ORCID: https://orcid.org/0000-0002-7981-2073)
- Frederike Cosima Oertel (ORCID: https://orcid.org/0000-0003-4906-5983)
- Tanja Schmitz‐Hübsch (ORCID: https://orcid.org/0000-0003-4833-5937)
- Nadja Siebert (ORCID: https://orcid.org/0000-0001-6576-7761)
- Murat Delikaya (ORCID: https://orcid.org/0009-0009-0438-8771)
- Lidia Kilinska
Institutions
- Max Delbrück Center (DE)
- Humboldt-Universität zu Berlin (DE)
- Einstein Center Digital Future (DE)
- Freie Universität Berlin (DE)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- Multiple Sclerosis Journal - Experimental Translational and Clinical
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1177/20552173251397772
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00